fbpx

Idogen – The Q3 quarterly report

Idogen - The Q3 quarterly report 26 OktoberOkt 2021 11:30 - 11:50Online Event

Idogen – The Q3 quarterly report

Meet and ask questions to CEO, Anders Karlsson when he presents the quarterly Q3 report.

Idogen is a Swedish Biotech company. The company develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues. The term “tolerogenic” refers to the immune system’s selective tolerance of a specific pathogenic or immune activating antigen following treatment with Idogen’s therapy.

The company announce the result the 26th in the morning.

Deltag her

Du vil blive videresendt til en ekstern tilmeldingsside. 

Information

Idogen - The Q3 quarterly report 26 OktoberOkt 2021 11:30 - 11:50
Idogen - The Q3 quarterly report Online Event
Idogen - The Q3 quarterly report 26 OktoberOkt 2021 11:30 - 11:50Online Event

Idogen – The Q3 quarterly report

Meet and ask questions to CEO, Anders Karlsson when he presents the quarterly Q3 report.

Idogen is a Swedish Biotech company. The company develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues. The term “tolerogenic” refers to the immune system’s selective tolerance of a specific pathogenic or immune activating antigen following treatment with Idogen’s therapy.

The company announce the result the 26th in the morning.

Information

Idogen - The Q3 quarterly report 26 OktoberOkt 2021 11:30 - 11:50
Idogen - The Q3 quarterly report Online Event